What We Do

New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Covid-19  and CNS Disorders.

COVID-19

Developing and delivering therapies which safely and effectively treat Covid-19
Learn More

Progressive Supranuclear Palsy

Developing first-in-line therapies for orphan neurodegenerative disorders like Progressive Supranuclear Palsy (PSP).
 
Learn More

Influenza

Developing targeted therapies and adjuvants for influenza which have demonstrated greater efficacy than Tamiflu, the current “gold standard.”
 
Learn More

Radiomitigators

Developing radiation mitigators to treat the difficult side effects that can occur from undergoing radiation therapy for cancer, as well as biodefense applications.
 
Learn More

Narrow focus, open minds

NAS pursues novel treatments to enhance the lives of patients in multiple areas of development in order to yield more opportunities.
 
Other Areas of Interest

 

Covid Hot Spots

covid-19 widget

© 2020 New Amsterdam Sciences | Terms of Use | Privacy PolicyContact Us

STAYING AHEAD OF COVID-19

New Amsterdam Sciences is committed to the fight, Our Fight Against the Rapidly Evolving COVID-19 Pandemic